{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-078484","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2022-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.409393+00:00","generated_at":"2026-06-26T21:57:18.771652+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aadi Bioscience enters $75M ATM equity offering agreement with Cowen","bullets":["ATM facility allows Aadi to sell up to $75M in common stock at its discretion.","Cowen will receive 3.0% commission on gross proceeds from any shares sold.","Sales will be made on Nasdaq under existing shelf registration statement (S-3).","Aadi has no obligation to sell any shares; program effective March 17, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-078484","json":"https://secwatch.observer/filing/0001193125-22-078484.json","markdown":"https://secwatch.observer/filing/0001193125-22-078484.md","text":"https://secwatch.observer/filing/0001193125-22-078484.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312522078484/0001193125-22-078484-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312522078484/d266766d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:57:18.771652+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}